Slide 1
Slide 1
Slide 1

Foundayo®

FDA Approved

Details

Foundayo is a prescription medicine used with a reduced-calorie diet and increased physical activity to help adults with obesity, or some adults with overweight who also have weight-related medical problems, to lose excess body weight and keep the weight off.

Foundayo is a prescription medicine used with a reduced-calorie diet and increased physical activity to help adults with obesity, or some adults with overweight who also have weight-related medical problems, to lose excess body weight and keep the weight off.

Foundayo® stands out as an innovative, FDA-approved option for individuals seeking structured, long-term weight management with the convenience of a once-daily pill. Key advantages include:

FDA-approved for chronic weight management
Specifically indicated for adults with obesity, or adults with overweight plus weight-related medical problems, when used with a reduced-calorie diet and increased physical activity.

Once-daily oral convenience
Foundayo is a daily tablet designed to fit into real-life routines and can be taken any time of day without food or water restrictions.

Targets appetite regulation at the hormonal level
As a GLP-1 receptor agonist, Foundayo works with the body’s natural pathways involved in hunger and fullness, helping reduce appetite and support healthier eating habits.

Clinically meaningful results
In clinical studies, adults taking the 17.2 mg dose lost up to approximately 25 pounds (~11%) over 72 weeks when combined with diet and exercise. Individual results may vary.

Supports keeping weight off
Beyond weight loss, Foundayo is indicated to help patients maintain weight reduction long term as part of an ongoing medical plan.

Provider-guided treatment
Foundayo requires a prescription, allowing treatment to be managed with professional oversight, dose adjustments, and continued support based on individual needs.

Through Naked Rx, Foundayo can be offered as part of a medically guided program focused on safety, personalization, and long-term success.

Wegovy Consultation

Premium Care
Without Compromise

Personalized Wellness

Custom treatment plans designed around your body, goals, and lifestyle.

Expert-Led Care

Dedicated support from licensed providers committed to your success.

Convenient Access

Premium healthcare and prescriptions delivered without the waiting room.

Long-Term Results

Ongoing monitoring and treatment optimization to help you achieve lasting outcomes.

Not just a shot
A system.

- %

Body fat reduced

- 0 lbs

Avg. weight lost (18 mo.)

- 0 %

Craving reduction

Feature Wegovy® Pill (Semaglutide) Wegovy® Pill (Semaglutide) Foundayo® (Orforglipron) Foundayo® (Orforglipron)
Active Ingredient Semaglutide Orforglipron
Medication Class GLP-1 receptor agonist GLP-1 receptor agonist
Dosing schedule Once dailly Once dailly
FDA Approval Approved for chronic weight management in adults with obesity or overweight plus weight-related conditions Approved for chronic weight management in adults with obesity or overweight plus weight-related conditions
Dosing Flexibility Can be taken any time of day, with or without food or water restrictions Typically requires taking on an empty stomach with water and waiting before eating
Weight Loss Results Clinical studies showed meaningful weight loss, with highest-dose users averaging up to 27 lbs lost in trials Clinical studies showed significant weight loss, with averages reported around 15%+ depending on study population
Best For Patients wanting a simple oral GLP-1 without timing restrictions Patients wanting a clinically proven semaglutide oral option
Prescription Medication (Paid Only if Approved) From $149/mo From $149/mo

Switch to Naked Rx

Bare numbers. Clear signal.

Six calculators that tell you the truth. BMI. TDEE. Protein. Carbs. Calorie deficit. Daily water. Numbers are not a verdict—they are a starting point.

Updated from your entries

BMI range may warrant provider review

29.0

Your number is not the answer. It is the starting line. A licensed provider reviews everything before treatment is recommended.

Start the assessment

Uncomplicated care,
in your hands.

Six calculators. Six protocols.

One assessment that takes sixty seconds. Built for people
who want healthcare stripped of friction.

Luxury Healthcare
On Your Terms

Complete a quick online assessment, connect with a licensed provider, and receive a customized treatment plan delivered directly to your door.

Choose Your
Treatment

Complete Your
Online Intake

Connect with Our
Licensed Provider

Get Meds Delivered
to Your Door

Frequently Asked Questions

Wegovy® (semaglutide 2.4 mg) is an FDA-approved, once-weekly injectable medication for chronic weight management in adults with a BMI of 30+ or 27+ with at least one weight-related condition.

It works as a GLP-1 receptor agonist — mimicking a natural gut hormone that signals fullness to the brain, slowing digestion and reducing appetite. In clinical trials (STEP program), participants lost an average of ~15% of their body weight over 68 weeks.

GLP-1 also reduces the speed at which food passes through the digestive system. It prolongs digestion, helping to maintain your feeling of fullness for a longer period. Therefore, when you take GLP-1 injections, you feel fuller faster and are less likely to overeat.

One of the key benefits of GLP-1 is its ability to suppress appetite, helping you feel fuller for longer and reducing cravings for unhealthy foods. By curbing your appetite, GLP-1 makes it easier to stick to your dietary goals and maintain a healthy lifestyle.

GLP-1 also plays a crucial role in regulating blood sugar levels. By enhancing insulin sensitivity and reducing glucose production in the liver, GLP-1 helps keep blood sugar levels stable, which is essential for overall health and well-being.

Both Wegovy® and Zepbound® are self-administered as a once-weekly subcutaneous injection — meaning a small needle goes just under the skin, typically in the abdomen, thigh, or upper arm.

Each comes in a pre-filled autoinjector pen that makes dosing simple. Your provider will walk you through the technique, and Kin Meds provides detailed injection instructions with your shipment. Doses are gradually increased over the first several months to minimize side effects.

In the SURMOUNT clinical trials, patients on the highest dose lost an average of ~22.5% of body weight, outperforming Wegovy® in head-to-head data. It’s generally considered the more powerful option but may have different insurance coverage and availability depending on your state.

General FDA eligibility guidelines require:

  • BMI of 30 or higher, OR
  • BMI of 27 or higher plus at least one weight-related condition (e.g., high blood pressure, Type 2 diabetes, high cholesterol)

Final eligibility is determined by your licensed provider after reviewing your health intake and lab results. Not all applicants will qualify. Certain medical conditions and medications may be contraindications.

Insurance coverage for branded GLP-1 medications varies significantly by plan. Wegovy® currently has broader insurance coverage than Zepbound®, particularly under plans that cover anti-obesity medications.

Naked Rx operates as a cash-pay program — we provide transparent pricing without relying on insurance approval. However, some patients choose to submit for reimbursement independently through their insurance after receiving their prescription.

The $49 application and screening fee covers the cost of the at-home blood test and clinical intake review — this fee applies regardless of the outcome and is non-refundable as services are rendered during the screening process.

You will not be charged for medication unless a prescription is written and approved. Please review our full Returns & Refund Policy for details.

Naked Rx currently serves patients across most US states. Availability may vary based on state-specific prescribing regulations. During your intake, you’ll be notified if service is not yet available in your state.

Medications are shipped directly to your door in discreet, temperature-controlled packaging by a licensed third-party pharmacy.